Actively Recruiting
Development of a New Method for Liver Stiffness Measurement Using FibroScan
Led by Echosens · Updated on 2025-08-14
114
Participants Needed
2
Research Sites
133 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
CONDITIONS
Official Title
Development of a New Method for Liver Stiffness Measurement Using FibroScan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
- Adult patient able to give his written consent
- Patient affiliated to the French Social Security system
You will not qualify if you...
- Vulnerable patients
- Patients with liver ascites
- Patients with heart failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Groupe Hospitalier Nord Essonne - Site Paris- Saclay
Orsay, France, 91400
Actively Recruiting
2
Hôpital Pitié-Salpêtrière
Paris, Île-de-France Region, France, 75013
Actively Recruiting
Research Team
A
Anne Llorca
CONTACT
L
Laura Cantu-Sanchez
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here